Asset Details
Do you wish to reserve the book?
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Do you wish to request the book?
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
2018
Overview
Recent studies suggest that some monoclonal antibodies (mAbs) specific for ebolavirus glycoprotein (GP) can protect experimental animals against infections. Most mAbs isolated from ebolavirus survivors appeared to target the glycan cap or the stalk region of the viral GP, which is the envelope protein and the only antigen inducing virus-neutralizing antibody response. Some of the mAbs were demonstrated to be protective in vivo. Here, a panel of mAbs from four individual survivors of ebolavirus infection that target the glycan cap or stem region were selected for investigation of the mechanisms of their antiviral effect. Comparative characterization of the inhibiting effects on multiple steps of viral replication was performed, including attachment, post-attachment, entry, binding at low pH, post-cleavage neutralization of virions, viral trafficking to endosomes, cell-to-cell transmission, viral egress, and inhibition when added early at various time points post-infection. In addition, Fc-domain related properties were characterized, including activation and degranulation of NK cells, antibody-dependent cellular phagocytosis and glycan content. The two groups of mAbs (glycan cap versus stem) demonstrated very different profiles of activities suggesting usage of mAbs with different epitope specificity could coordinate inhibition of multiple steps of filovirus infection through Fab- and Fc-mediated mechanisms, and provide a reliable therapeutic approach.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Antibodies, Monoclonal - immunology
/ Antibodies, Viral - immunology
/ Antigens
/ Complications and side effects
/ Disease
/ Egress
/ Epitopes
/ Glycan
/ Hemorrhagic Fever, Ebola - immunology
/ Humans
/ Medicine and Health Sciences
/ Research and Analysis Methods
/ Vaccines
/ Viral Envelope Proteins - antagonists & inhibitors
/ Virions
/ Viruses
